Myoepithelial Tumor of Soft Tissue With the Novel IRF2BP2::CDX1 Gene Fusion

Rana Naous1, Ricardo Diaz-Aragon2, Arivarasan Karunamurthy1

  • 1Pathology, University of Pittsburgh Medical Center, Pittsburgh, USA.

Cureus
|September 22, 2025
PubMed

Insights

This study identifies a novel gene fusion, IRF2BP2::CDX1, in an EWSR1-negative myoepithelial tumor of soft tissue. This finding expands the understanding of rare soft tissue neoplasms and their molecular underpinnings.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • Myoepithelial tumors of soft tissue are mesenchymal neoplasms often characterized by EWSR1 or FUS gene fusions.
  • EWSR1-negative gene fusions are infrequently documented in these rare tumors.